Table 2 Amino acids substitutions in the active site of cruzipains and frequency of interactions of each position with cruzain ligands.
Sub-type/Archetypea | Residue | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3 | S2 | S1 | S1′ | S2/S1′ | |||||||||
Cruzipain 1 | S61 | N70 | L67 | M68 | N69 | A138 | G163 | E208 | S64 | S142 | M145 | D161 | Q159 |
Cruzipain 2 | F | K | S | S | L | A | A | E | G | T | M | N | R |
Cruzipain 3 (czp.3.II.4_EL) | F | K | W | P | L | T | A | E | G | T | I | S | T |
Cruzipain 3 (czp.3.II.9_NEL) | S | V | W | P | L | A | A | E | G | S | I | S | Q |
Cruzipain 4 | S | V | S | P | L | A | A | G | G | S | M | D | K |
Frequency of interaction with crystallographic ligands (%)b | 0.0 | 0.0 | 79.2 | 70.8 | 0.0 | 83.3 | 0.0 | 41.7 | 3.0 | 0.0 | 29.2 | 50.0 | 4.2 |